Showing results (51-60 of 241) with videos related to
Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2012
Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumorsAung Naing, Patricia LoRusso, Siqing Fu, et al.Hepato-Gastroenterology|March 18, 2014
Hepatic arterial infusion therapy in advanced cancer and liver-predominant disease: the MD Anderson ExperienceApostolia M Tsimberidou, Christos Vaklavas, Siqing Fu, et al.Plos One|August 11, 2011
PIK3CA mutations frequently coexist with RAS and BRAF mutations in patients with advanced cancersFilip Janku, J Jack Lee, Apostolia M Tsimberidou, et al.British Journal of Clinical Pharmacology|April 29, 2016
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairmentNeeraj Gupta, Michael J Hanley, Karthik Venkatakrishnan, et al.The Oncologist|June 5, 2024
Metastatic extraneural glioblastoma diagnosed with molecular testingNazanin K Majd, Henry Hiep Vo, Cesar A Moran, et al.Cancer Chemotherapy and Pharmacology|April 18, 2016
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancerRabih Said, Eugenia Kakadiaris, Sarina Piha-Paul, et al.Oncotarget|April 19, 2014
Advanced gynecologic malignancies treated with a combination of the VEGF inhibitor bevacizumab and the mTOR inhibitor temsirolimusSarina A Piha-Paul, Jennifer J Wheler, Siqing Fu, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 15, 2015
Olanzapine for cachexia in patients with advanced cancer: an exploratory study of effects on weight and metabolic cytokinesAung Naing, Shalini Dalal, Maen Abdelrahim, et al.Clinical Colorectal Cancer|April 28, 2012
Outcomes in 144 patients with colorectal cancer treated in a phase I clinic: the MD Anderson Cancer Center experienceDavid S Hong, Jesal C Patel, Jennifer Wheler, et al.Cancer Chemotherapy and Pharmacology|March 6, 2010
Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvementApostolia M Tsimberidou, Stacy Moulder, Siqing Fu, et al.Pageof 25